Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Haleon Plc (HLN.LN)

Haleon Plc (HLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Haleon Plc The Heights Building 5, First Floor Weybridge KT13 0NY GBR

https://www.haleon.com P: 193-282-2000

Description:

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Key Statistics

Overview:

Market Capitalization, $K 33,106,280
Shares Outstanding, K 9,042,961
Annual Sales, $ 11,302 M
Annual Net Income, $ 1,049 M
Last Quarter Sales, $ 2,775 M
Last Quarter Net Income, $ 303,000 K
% of Insider Shareholders 0.01%
% of Institutional Shareholders 25.88%

Growth:

1-Year Return 11.87%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Most Recent Earnings 0.05 on 10/31/24
Next Earnings Date N/A
Earnings Per Share ttm 0.13
EPS Growth vs. Prev Qtr -28.26%
EPS Growth vs. Prev Year -10.75%
Annual Dividend Rate, $ 0.06
Annual Dividend Yield 1.69%
Most Recent Dividend 0.020 on 08/15/24
Next Ex-Dividends Date 08/15/24
Dividend Payable Date 09/19/24
Dividend Payout Ratio 46.97%

HLN.LN Ratios

Ratio
Price/Earnings ttm 27.73
Price/Earnings forward 19.88
Return-on-Equity % 6.58%
Return-on-Assets % 3.22%
Profit Margin % 9.28%
Debt/Equity 0.53
Price/Sales 2.99
Price/Book 1.99
Book Value/Share 1.84
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar